Moreover, IL-4 is thought to inhibit γδT cell-driven anti-tumor responses by directing the γδT cell population towards producing the immunosuppressive cytokine IL-10, thereby enhancing the expansion of the Vδ1+ subset and suppressing the IFN-γ-producing Vδ2+ subset [108]. The gene discussed is IL10; the disease is neoplasm.